Cargando…
Development of the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd)—a new patient-reported outcome measure
OBJECTIVE: The aim was to co-produce and test a potential new patient-reported outcome measure (PROM), the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd), providing vital qualitative confirmation of conceptual relevance, clarity and acceptability. METHODS: Informed by meas...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021732/ https://www.ncbi.nlm.nih.gov/pubmed/35465627 http://dx.doi.org/10.1093/rap/rkac027 |
_version_ | 1784689898549149696 |
---|---|
author | Pearson, Nathan A Tutton, Elizabeth Martindale, Jane Strickland, George Thompson, Jean Packham, Jonathan C Creamer, Paul Haywood, Kirstie L |
author_facet | Pearson, Nathan A Tutton, Elizabeth Martindale, Jane Strickland, George Thompson, Jean Packham, Jonathan C Creamer, Paul Haywood, Kirstie L |
author_sort | Pearson, Nathan A |
collection | PubMed |
description | OBJECTIVE: The aim was to co-produce and test a potential new patient-reported outcome measure (PROM), the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd), providing vital qualitative confirmation of conceptual relevance, clarity and acceptability. METHODS: Informed by measurement theory, we collaborated with patient partners throughout a three-stage, iterative process of PROM development. In stage 1, informed by patient interviews, reviews exploring patients’ fatigue experiences and existing PROMs of fatigue, an initial measurement framework of axial spondyloarthritis (axSpA) fatigue and energy and candidate items were defined. In stage 2, the relevance and acceptability of the measurement framework and candidate items were assessed qualitatively by focus group participants. In stage 3, patients participated in pre-testing interviews to assess item comprehensiveness, relevance, acceptability and comprehensibility. RESULTS: Stage 1 informed the development of an initial five-domain measurement framework with 59 candidate items. In stage 2, five patients and seven health-care professionals participated in four focus groups to derive a 40-item model of fatigue and energy. Collaborative engagement with patient research partners supported refinement of questionnaire structure and content further. Pre-testing with ten patients across two interview rounds in stage 3 produced a four-domain, 30-item long-form questionnaire. CONCLUSION: An active collaboration with patients and health-care professionals has supported the co-production of a potential new PROM of axSpA fatigue, underpinned by strong evidence of face and content validity. The WASTEd extends the assessment of fatigue beyond severity, highlighting the importance of symptom frequency, energy and self-management. Future research will involve psychometric evaluation, supporting item reduction, structural refinement and confirmation of PROM validity. |
format | Online Article Text |
id | pubmed-9021732 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-90217322022-04-21 Development of the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd)—a new patient-reported outcome measure Pearson, Nathan A Tutton, Elizabeth Martindale, Jane Strickland, George Thompson, Jean Packham, Jonathan C Creamer, Paul Haywood, Kirstie L Rheumatol Adv Pract Original Article OBJECTIVE: The aim was to co-produce and test a potential new patient-reported outcome measure (PROM), the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd), providing vital qualitative confirmation of conceptual relevance, clarity and acceptability. METHODS: Informed by measurement theory, we collaborated with patient partners throughout a three-stage, iterative process of PROM development. In stage 1, informed by patient interviews, reviews exploring patients’ fatigue experiences and existing PROMs of fatigue, an initial measurement framework of axial spondyloarthritis (axSpA) fatigue and energy and candidate items were defined. In stage 2, the relevance and acceptability of the measurement framework and candidate items were assessed qualitatively by focus group participants. In stage 3, patients participated in pre-testing interviews to assess item comprehensiveness, relevance, acceptability and comprehensibility. RESULTS: Stage 1 informed the development of an initial five-domain measurement framework with 59 candidate items. In stage 2, five patients and seven health-care professionals participated in four focus groups to derive a 40-item model of fatigue and energy. Collaborative engagement with patient research partners supported refinement of questionnaire structure and content further. Pre-testing with ten patients across two interview rounds in stage 3 produced a four-domain, 30-item long-form questionnaire. CONCLUSION: An active collaboration with patients and health-care professionals has supported the co-production of a potential new PROM of axSpA fatigue, underpinned by strong evidence of face and content validity. The WASTEd extends the assessment of fatigue beyond severity, highlighting the importance of symptom frequency, energy and self-management. Future research will involve psychometric evaluation, supporting item reduction, structural refinement and confirmation of PROM validity. Oxford University Press 2022-04-04 /pmc/articles/PMC9021732/ /pubmed/35465627 http://dx.doi.org/10.1093/rap/rkac027 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Pearson, Nathan A Tutton, Elizabeth Martindale, Jane Strickland, George Thompson, Jean Packham, Jonathan C Creamer, Paul Haywood, Kirstie L Development of the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd)—a new patient-reported outcome measure |
title | Development of the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd)—a new patient-reported outcome measure |
title_full | Development of the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd)—a new patient-reported outcome measure |
title_fullStr | Development of the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd)—a new patient-reported outcome measure |
title_full_unstemmed | Development of the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd)—a new patient-reported outcome measure |
title_short | Development of the Warwick Axial Spondyloarthritis faTigue and Energy questionnaire (WASTEd)—a new patient-reported outcome measure |
title_sort | development of the warwick axial spondyloarthritis fatigue and energy questionnaire (wasted)—a new patient-reported outcome measure |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021732/ https://www.ncbi.nlm.nih.gov/pubmed/35465627 http://dx.doi.org/10.1093/rap/rkac027 |
work_keys_str_mv | AT pearsonnathana developmentofthewarwickaxialspondyloarthritisfatigueandenergyquestionnairewastedanewpatientreportedoutcomemeasure AT tuttonelizabeth developmentofthewarwickaxialspondyloarthritisfatigueandenergyquestionnairewastedanewpatientreportedoutcomemeasure AT martindalejane developmentofthewarwickaxialspondyloarthritisfatigueandenergyquestionnairewastedanewpatientreportedoutcomemeasure AT stricklandgeorge developmentofthewarwickaxialspondyloarthritisfatigueandenergyquestionnairewastedanewpatientreportedoutcomemeasure AT thompsonjean developmentofthewarwickaxialspondyloarthritisfatigueandenergyquestionnairewastedanewpatientreportedoutcomemeasure AT packhamjonathanc developmentofthewarwickaxialspondyloarthritisfatigueandenergyquestionnairewastedanewpatientreportedoutcomemeasure AT creamerpaul developmentofthewarwickaxialspondyloarthritisfatigueandenergyquestionnairewastedanewpatientreportedoutcomemeasure AT haywoodkirstiel developmentofthewarwickaxialspondyloarthritisfatigueandenergyquestionnairewastedanewpatientreportedoutcomemeasure |